ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1669

Will Investigators Enroll? A Vignette Study to Gauge Investigator Equipoise in a Trial of Surgery vs. Nonoperative Therapy in Subjects with Meniscal Tear and Persistent Pain Following Physical Therapy

Jeffrey Katz1, Faith Selzer2, Katharine Fox3, Jon Dhani3, Kyna Long3, Andrea Carland4, Tiffany Thavison4, Leslie Bisson4, Morgan Jones3, Katherine Krupa3 and Nomi Weiss-laxer5, 1Brigham and Women's Hospital, Brookline, MA, 2Brigham and Women's Hospital, Amesbury, MA, 3Brigham and Women's Hospital, Boston, MA, 4University at Buffalo, Buffalo, NY, 5U, Buffalo, NY

Meeting: ACR Convergence 2024

Keywords: clinical trial, Orthopedics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Clinician investigators may be unwilling to enroll all eligible subjects into randomized controlled trials (RCTs) because they feel certain subjects would benefit more from one treatment than the other. Lack of equipoise can slow trial enrollment and bias the sample. We are planning an RCT of arthroscopic partial meniscectomy (APM) vs. enhanced nonoperative therapy (Nonop+) for persons with meniscal tear (MT) and knee osteoarthritis (OA) who remain symptomatic after a course of physical therapy. We conducted a mixed methods study to assess equipoise among enrolling clinicians.

Methods: We developed 29 vignettes of hypothetical patients, all of whom met the eligibility criteria for the trial. We randomly varied 11 vignette features including age, sex, body mass index, symptom type and duration, walking distance, radiographic OA severity, and type of tear. 15 clinicians (orthopedists and physician assistants) participated and used an online polling system to express their willingness to enroll each case as: “Yes, randomize,” “No, advise surgery,” or “No, advise Nonop+.” We conducted a moderated discussion over Zoom following polling, which was recorded and transcribed. The quantitative analysis assessed the number of cases each clinician was willing to enroll and identified clinical features associated with the likelihood of enrollment.  To identify factors independently associated with clinicians’ decision to enroll, we performed multivariate logistic regression, accounting for clustering by clinician. We also performed a thematic analysis of the discussion among clinicians.

Results: The 15 clinicians rated 427 vignettes and were willing to enroll 71% (range 24-100%). Among cases clinicians were unwilling to enroll, they favored surgery in 17% and the Nonop+ treatment in 12%. Three clinicians were willing to enroll < 50% of cases. Clinicians were willing to enroll 39% of vignettes with bucket handle tears, as compared with 77% with other tear types (Table).  Clinicians were less willing to enroll cases who could not walk >200 yards, who had KL 3 radiographs, and who did not have joint line tenderness (Table). In multivariable logistic regression analyses, bucket handle tear (adjusted OR (aOR) 0.12, 95% CI 0.04, 0.37) and KL3 radiographs (aOR 0.54, 95% CI 0.36, 0.82) were independently associated with unwillingness to randomize at p< 0.01. The qualitative analysis affirmed that clinicians were less inclined to randomize subjects with severe osteoarthritis or marked functional limitation because they favored conservative care, while they were less inclined to randomize subjects with bucket handle tears because they favored surgery.

Conclusion: This vignette-based methodology can be used to project the proportion of eligible subjects that clinicians are likely to enroll in an RCT. The method can also identify clinicians who should be engaged in discussions about equipoise or excluded from the study (e.g. our 3 clinicians willing to randomize < 50% of cases). Finally, it can identify potential modifications in exclusion criteria (e.g., exclude bucket handle tears) that would increase the proportion of eligible subjects randomized.

Supporting image 1


Disclosures: J. Katz: None; F. Selzer: None; K. Fox: None; J. Dhani: None; K. Long: None; A. Carland: None; T. Thavison: None; L. Bisson: None; M. Jones: Grunenthal, 1, Journal of Bone and Joint Surgery, 12, Online learning editor; K. Krupa: None; N. Weiss-laxer: None.

To cite this abstract in AMA style:

Katz J, Selzer F, Fox K, Dhani J, Long K, Carland A, Thavison T, Bisson L, Jones M, Krupa K, Weiss-laxer N. Will Investigators Enroll? A Vignette Study to Gauge Investigator Equipoise in a Trial of Surgery vs. Nonoperative Therapy in Subjects with Meniscal Tear and Persistent Pain Following Physical Therapy [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/will-investigators-enroll-a-vignette-study-to-gauge-investigator-equipoise-in-a-trial-of-surgery-vs-nonoperative-therapy-in-subjects-with-meniscal-tear-and-persistent-pain-following-physical-therapy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/will-investigators-enroll-a-vignette-study-to-gauge-investigator-equipoise-in-a-trial-of-surgery-vs-nonoperative-therapy-in-subjects-with-meniscal-tear-and-persistent-pain-following-physical-therapy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology